Platelet activation and inhibition. Novel signal transduction mechanisms.
Peterson
S N
SN
Division of Cell Biology, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.
Lapetina
E G
EG
D000595:Amino Acid Sequence; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D017868:Cyclic AMP-Dependent Protein Kinases / Q000097:blood; D019204:GTP-Binding Proteins / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D016285:Iloprost / Q000494:pharmacology; D008969:Molecular Sequence Data; D015689:Oncogene Protein p21(ras) / Q000737:chemistry; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology*; D011487:Protein Conformation; D016283:Proto-Oncogene Proteins p21(ras) / Q000737:chemistry; D018179:Receptors, Thrombin / Q000737:chemistry / Q000502:physiology; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D010738:Type C Phospholipases / Q000097:blood; D020668:rap GTP-Binding Proteins
D018179:Receptors, Thrombin; D017868:Cyclic AMP-Dependent Protein Kinases; D010738:Type C Phospholipases; D019204:GTP-Binding Proteins; C501009:HRAS protein, human; D015689:Oncogene Protein p21(ras); D016283:Proto-Oncogene Proteins p21(ras); D020668:rap GTP-Binding Proteins; D016285:Iloprost